| Dr Christopher Robert Manees, MD | |
|
1564 Kingsley Ave, Orange Park, FL 32073-4521 | |
| (904) 264-8801 | |
| (833) 578-1805 |
| Full Name | Dr Christopher Robert Manees |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 18 Years |
| Location | 1564 Kingsley Ave, Orange Park, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528276771 | NPI | - | NPPES |
| 96064 | Other | GA | GA MEDICAL LICENSE |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians Group Services Pa | 1254238579 | 82 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
Taking aspirin after being diagnosed with bowel cancer can reduce the chance of dying from the disease by 30 per cent, new research shows today.
Incyte Corporation announced today positive top-line results from COMFORT-I, the pivotal Phase III clinical trial of INCB18424 (also known as INC424) in patients with myelofibrosis (MF) being conducted under a Food and Drug Administration (FDA) Special Protocol Assessment (SPA) Agreement. COMFORT-I (COntrolled MyeloFibrosis Study with ORal JAK Inhibitor Treatment) is a double-blind, placebo-controlled Phase III trial involving 309 patients.
Off-label prescription of a drug is generally legal, but promotion of off-label uses by a drug manufacturer is illegal. In an article in this week's PLoS Medicine, two physician researchers describe the techniques that drug companies use to covertly promote off-label use, even when such promotion is illegal.
Scientists are reporting development of a fast, simple, inexpensive method for determining whether chemicals in consumer products and workplaces may cause skin allergies in people - a method that does not involve use of animals. Their study appears in ACS' Chemical Research in Toxicology, a monthly journal.
› Verified 4 days ago
| Entity Name | Physicians Group Services Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861440810 PECOS PAC ID: 1254238579 Enrollment ID: O20031216000099 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
Taking aspirin after being diagnosed with bowel cancer can reduce the chance of dying from the disease by 30 per cent, new research shows today.
Incyte Corporation announced today positive top-line results from COMFORT-I, the pivotal Phase III clinical trial of INCB18424 (also known as INC424) in patients with myelofibrosis (MF) being conducted under a Food and Drug Administration (FDA) Special Protocol Assessment (SPA) Agreement. COMFORT-I (COntrolled MyeloFibrosis Study with ORal JAK Inhibitor Treatment) is a double-blind, placebo-controlled Phase III trial involving 309 patients.
Off-label prescription of a drug is generally legal, but promotion of off-label uses by a drug manufacturer is illegal. In an article in this week's PLoS Medicine, two physician researchers describe the techniques that drug companies use to covertly promote off-label use, even when such promotion is illegal.
Scientists are reporting development of a fast, simple, inexpensive method for determining whether chemicals in consumer products and workplaces may cause skin allergies in people - a method that does not involve use of animals. Their study appears in ACS' Chemical Research in Toxicology, a monthly journal.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Robert Manees, MD 705 Wells Rd Ste 300, Orange Park, FL 32073-2982 Ph: (904) 282-6331 | Dr Christopher Robert Manees, MD 1564 Kingsley Ave, Orange Park, FL 32073-4521 Ph: (904) 264-8801 |
News Archive
The findings, which are published in the current edition of the Journal of Epidemiology and Community Health, conclude that although successful campaigns to get Scots to live a healthier lifestyle will reduce rates of heart disease in Scotland, they will not do much to narrow the gap in heart disease rates between Scotland and England.
Taking aspirin after being diagnosed with bowel cancer can reduce the chance of dying from the disease by 30 per cent, new research shows today.
Incyte Corporation announced today positive top-line results from COMFORT-I, the pivotal Phase III clinical trial of INCB18424 (also known as INC424) in patients with myelofibrosis (MF) being conducted under a Food and Drug Administration (FDA) Special Protocol Assessment (SPA) Agreement. COMFORT-I (COntrolled MyeloFibrosis Study with ORal JAK Inhibitor Treatment) is a double-blind, placebo-controlled Phase III trial involving 309 patients.
Off-label prescription of a drug is generally legal, but promotion of off-label uses by a drug manufacturer is illegal. In an article in this week's PLoS Medicine, two physician researchers describe the techniques that drug companies use to covertly promote off-label use, even when such promotion is illegal.
Scientists are reporting development of a fast, simple, inexpensive method for determining whether chemicals in consumer products and workplaces may cause skin allergies in people - a method that does not involve use of animals. Their study appears in ACS' Chemical Research in Toxicology, a monthly journal.
› Verified 4 days ago
Dr. Theresa J Cumpstone, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1665 Kingsley Ave, Suite 105, Orange Park, FL 32073 Phone: 904-215-7015 | |
Anthony Valachovic, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1665 Kingsley Ave, Suite 105, Orange Park, FL 32073 Phone: 904-215-7015 | |
Omar M Garcia, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2021 Kingsley Ave, Suite 105, Orange Park, FL 32073 Phone: 904-276-5400 Fax: 904-276-5430 | |
Mark Zapp, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 2001 Kingsley Ave, Orange Park, FL 32073 Phone: 904-421-2119 | |
Carla J Pardo, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2021 Kingsley Ave, Suite 105, Orange Park, FL 32073 Phone: 904-276-5400 Fax: 904-276-5430 | |
Dr. Karin Herzele Vangura, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1564 Kingsley Ave, Orange Park, FL 32073 Phone: 904-282-6331 Fax: 904-619-1080 | |
Ellen Rose Abellana, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2001 Kingsley Ave, Orange Park, FL 32073 Phone: 904-215-7015 |